Light Therapy holds promise as a treatment for Alzheimer's Disease

A new article, conducted by Lili Zang and colleagues from Weifang Medical University School of Nursing in Shandong Province, China, discusses a meta-analysis of 15 high-quality trials that investigated the impact of light therapy on individuals with Alzheimer’s disease (AD).

The meta-analysis included 598 patients with mild to moderate Alzheimer’s disease, and it covered 15 randomized controlled trials conducted in seven different countries. Those trials were published between 2005 and 2022.

Sleep Improvement

Light therapy led to significant improvements in several sleep measures. It notably enhanced sleep efficiency, increased interdaily stability, and reduced intradaily variability, all of which are indicators of better sleep quality.

Light therapy was associated with a reduction in agitation, depression, and caregiver burden among individuals with Alzheimer’s disease.

A significant advantage over usual care was shown in reducing the severity of psychobehavioral symptoms, as assessed by the Neuropsychiatric Inventory.

Not in Cognitive Function

While light therapy had positive effects on sleep and psychological well-being, it did not show a statistically significant effect on improving cognitive function, as measured by the Mini-Mental State Examination.

The study suggests that light therapy has low side effects, making it a promising treatment for Alzheimer’s disease.

However, the authors also highlight the importance of considering adverse behavioral outcomes in patients due to exposure to bright light.

The meta-analysis acknowledges some limitations, including inconsistencies in the types and degrees of dementia in the included studies, which may affect the outcome indicators.

In summary, the findings suggest that light therapy holds promise as a treatment for Alzheimer’s disease, particularly in improving sleep quality and alleviating psychological symptoms. The study emphasizes the need to weigh the benefits of light therapy against potential adverse effects and acknowledges certain limitations in the available research.

👉Explore marketed lamps

References

Light Therapy a Beacon of Hope for Alzheimer's?

https://www.medscape.com/viewarticle/light-therapy-beacon-hope-alzheimers-2023a1000vk4

Zang L, Liu X, Li Y, et al. The effect of light therapy on sleep disorders and psychobehavioral symptoms in patients with Alzheimer’s disease: A meta-analysis. PLoS One. 2023;18(12):e0293977. doi:10.1371/journal.pone.0293977

Comments

Exploring the Link Between Circadian Rhythms, Longevity, and Wearable Data: Insights and Future Directions

A recent study in NHANES 2011–2014 explores the potential connection between disruptions in circadian rhythms, measured using wearable devices, and their impact on health outcomes and longevity. The study analyzes data from 7,297 U.S. adults collected through wearable accelerometers as a novel digital biomarker for longevity. Five distinct clusters were identified based on activity profiles: "High activity," "Low activity," "Mild circadian rhythm (CR) disruption," "Severe CR disruption," and "Very low activity." The findings reveal that young adults with extreme circadian rhythm disturbance exhibit higher white blood cell counts and accelerated biological aging. Older adults with circadian disruption are associated with increased systemic inflammation indexes, advanced biological aging, and higher all-cause mortality risk. The research underscores the importance of circadian alignment for longevity at all ages and suggests that wearable

The safety of aspartame is under review by WHO after conflicting findings.

Aspartame, a sweetener with health effects Since 1981, the WHO expert committee on additives has confirmed the safety of aspartame consumption within acceptable daily limits. The international organization has established that the acceptable daily intake (ADI) of aspartame is 40 milligrams per kilogram of body weight. This means that a person can consume up to 40 mg of aspartame per kilogram of their body weight per day without risking their health. For example, if someone weighs 60 kilos, the allowable amount of aspartame would be 2,400 milligrams (40 mg/kg x 60 kg). In recent years, several studies have been carried out on the effects of aspartame on health. The Food and Drug Administration (FDA) has reviewed the scientific evidence related to the safety of this sweetener five times since its approval in 1981, and has concluded that it remains safe for use. However, it is being studied again. It has an especially important use in low-calorie beverages consumed by children and pregnan

Multivitamins Can Improve Memory in Older Adults

A recent clinical trial called COSMOS suggests that taking multivitamins may improve memory and slow cognitive aging in older adults. The trial involved 3,500 participants aged 60 or older and found that the multivitamin group performed better on memory tests compared to the placebo group. The benefits were equivalent to slowing age-related memory loss by about 3 years. The study also noted that individuals with a history of cardiovascular disease experienced the greatest benefits. It's important to remember that multivitamins should not replace a healthy lifestyle, and high doses of isolated micronutrients may not provide the same benefits. The trial found that multivitamins were safe to use, and further research is needed to understand who will benefit the most and the underlying mechanisms involved. Source: ok-Kin Yeung, Daniel M. Alschuler, Melanie Wall, Heike Luttmann-Gibson, Trisha Copeland, Christiane Hale, Richard P. Sloan, Howard D. Sesso, JoAnn E. Manson, Adam M. B

Wellness-uptodate

Search This Blog